Organon & Co.
S&P 600
$13.64
+0.07%
Delayed · cached 15 min
Fair value analysis
OGN
Organon & Co.
$13.64
Close used for this calculation
$22.69Fair value
Financial DNA Score
Profitability · Returns · Balance Sheet · Efficiency · Growth
59/100
Quality radar
Consensus fair value
$22.69
Below FV▲ +66.3% against the close used
Model range $4.33 – $38.82
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.
Price target range & 52-week position
Bear$4.33Fair value$22.69Bull$38.82
FairClose
52-week traded range
52W low $5.7052W high $13.78
The 52-week range is measured from the stored price history, not estimated.
Valuation summary
Trading below the consensus fair value
Organon & Co. closed at $13.64, 39.9% below the consensus fair value of $22.69 drawn from 7 valuation models.
Financial DNA score 59/100 — Good. P/E of 18.9x against the 20x sector multiple the P/E model uses.
Quantitative summary only — not investment advice.
All valuation models
DCF Valuation
$38.82
+184.6%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=8%, r=10%, tg=3%, n=10yr
P/E Fair Value
$14.40
+5.6%
EPS × 20x (sector P/E)
EPS=0.72, Sector P/E=20x
Peter Lynch (PEG)
$21.60
+58.4%
EPS × Growth% (PEG = 1 is fair)
EPS=0.72, g=30%
Dividend Discount (DDM)
$4.33
-68.3%
D1 ÷ (r − g) where D1 = D0×(1+g)
D0=0.34, r=10%, g=2%
Book Value (P/B)
$8.28
-39.3%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=3.72, ROE=18.6%, g=3%, r=10%
Reverse DCF
$13.64
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 6.4% | Historical: -38%
Margin of Safety
$19.96
+46.3%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=26.61, MoS=25%
Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.
Educational data only. Not a recommendation to buy, sell or hold any security.